PNC Financial Services Group
MIST icon

PNC Financial Services Group’s Milestone Pharmaceuticals MIST Stock Holding History

PNC Financial Services Group’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75K Buy
2,800
+1,800
+180% +$2.88K ﹤0.01% 4491
2026
Q1 		$1.19K Buy
+1,000
New +$1.75K ﹤0.01% 4714
2023
Q1 		– Sell
-137
Closed -$543 – 4771
2022
Q4 		$543 Hold
137
– – ﹤0.01% 4517
2022
Q3 		$1K Buy
+137
New +$1.04K ﹤0.01% 4334

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

PNC Financial Services Group's MIST Position: Q2 2026 in Review

PNC Financial Services Group increased its Milestone Pharmaceuticals (MIST) stake by 180% in Q2 2026, buying an estimated $2.88K and bringing the position to 2,800 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #4491.

PNC Financial Services Group first reported a position in MIST in Q3 2022 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • PNC Financial Services Group held 2,800 shares of Milestone Pharmaceuticals worth $3.75K as of Q2 2026.
  • PNC Financial Services Group bought 1,800 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.88K.
  • Milestone Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4491 holding.
  • PNC Financial Services Group first reported a position in Milestone Pharmaceuticals in Q3 2022 and has held it in 4 quarters since.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.